Research directory

Drugs

Find a drug and open its page to see linked trials and published FDA events.

1840 drugs
Drug

(Z)-endoxifen

Drug identity checked against registry

Drug

0.5 mL dose of PCV20

Drug identity checked against registry

Drug

0.5 mL of the High-PFS dose VAX-31

Drug identity checked against registry

Drug

0.5 mL of the high dose VAX-31

Drug identity checked against registry

Drug

0.5 mL of the low dose VAX-31

Drug identity checked against registry

Drug

0.5 mL of the mid dose VAX-31

Drug identity checked against registry

Drug

0.5 mg epinephrine

Drug identity checked against registry

Drug

0.5 mg ranibizumab

Drug identity checked against registry

Drug

0.5 ml dose of 1.1 mcg VAX-24

Drug identity checked against registry

Drug

0.5 ml dose of 2.2 mcg VAX-24

Drug identity checked against registry

Drug

0.5 ml dose of 2.2/4.4 mcg VAX-24

Drug identity checked against registry

Drug

0.5 ml dose of PCV20

Drug identity checked against registry

Drug

0.5mg elsunersen

Drug identity checked against registry

Drug

1 mg epinephrine

Drug identity checked against registry

Drug

1.0mg/kg/day PRAX-562

Drug identity checked against registry

Drug

1.5mg/kg/day PRAX-562

Drug identity checked against registry

Drug

100 mg PRAX-944

Drug identity checked against registry

Drug

100 mg/m2 aldoxorubicin

Drug identity checked against registry

Drug

100 μg KIO-301

Drug identity checked against registry

Drug

131I-apamistamab

Drug identity checked against registry

Drug

150 mg/m2 aldoxorubicin

Drug identity checked against registry

Drug

1h Incubation Photodynamic therapy (PDT) (ALA-PDT, Ameluz®-PDT)

Drug identity not yet verified

Drug

1h Incubation Photodynamic therapy (PDT) (vehicle to BF-200 ALA containing no active ingredient)

Drug identity not yet verified

Drug

1mg elsunersen

Drug identity checked against registry

Drug

2.0 aflibercept

Drug identity checked against registry

Drug

2.0 mg OPT-302

Drug identity checked against registry

Drug

20 mg/day vormatrogine for 12 weeks

Drug identity checked against registry

Drug

200 mg pembrolizumab

Drug identity checked against registry

Drug

200-1600 µg of MBX 2109 once-weekly by subcutaneous injection

Drug identity checked against registry

Drug

20mg/day PRAX-628 for 6 weeks then 30mg/day PRAX-628 for remaining 6 weeks

Drug identity checked against registry